Colorectal Cancer
Clinical Trials

1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C mutation – 21 SLOTS AVAILABLE! USOR will NOT participate in the cohort sub-studies nor the fed state (food effect) cohort.

Send UsA Message

    Myra Walks in a Patient’s Shoes

    Myra Walks in a Patient’s Shoes

    In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.

    read more
    A Grateful Patient’s Breast Cancer Journey

    A Grateful Patient’s Breast Cancer Journey

    I am currently undergoing treatment for breast cancer at Roper St. Francis Hospital and would like to acknowledge two physicians who truly embody your mission of “healing with compassion, faith and excellence”.

    read more
    National Cancer Survivor Month

    National Cancer Survivor Month

    Please join Charleston Oncology and the American Association for Cancer Research (AACR) in support of National Survivor Month, celebrating those who have fought the disease and those currently in treatment.

    read more
    Call Now Button